Table 2

Clinical characteristics of 69 affected eyes at follow up

Group I classic syndrome
No (%)
Group II incomplete syndrome
No (%)
Number of eyes47 (100)22 (100)
Mean follow up (months)74 (2–264)37 (1–228)
Bilateral macular involvement9 patients (18%), 3 at presentation, 6 at follow up3 patients (10%), 1 at presentation, 2 at follow up
Visual acuity
 ≤ 20/20011 (23)6 (27)
 ≤ 20/4013 (28)4 (18)
 ≤ 20/4023 (49)12 (55)